跳至主要内容
临床试验/NCT07746310
NCT07746310已完成不适用

Nitrate, Nitrite and Phosphate and the Public Health - The Good and the Bad of Natural Components Ubiquitously Found in Our in Food and Drinking Water

Karolinska Institutet1 个研究点 分布在 1 个国家目标入组 86,000 人开始时间: 2026年8月5日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
86,000
试验地点
1
主要终点
Gastrointestinal cancers incidence

研究概览

简要总结

Nitrate, nitrite, and phosphate (NO3, NO2, P) are at all age stages ubiquitous in our everyday foods, including naturally occurring and as food additives, and in our drinking water. These compounds are essential in maintaining human well-being and health, but they have also been linked to detrimental health effects including contribution to cancer initiation and artery calcification, making it difficult to evaluate their overall health impact.

Therefore, the overarching aim of this project is to shed light on the potential dual effect of these compounds on a variety of chronic diseases (cardiovascular and respiratory diseases, gastrointestinal cancers) at different life stages and to further elucidate on the molecular mechanisms suggested to underly the pathogenesis of these disease outcomes.

This will be achieved by using prospective, longitudinal population-based cohorts linked to comprehensive databases of NO3 and NO2 and using a biomarker of P while also integrating omics data on inflammatory and cardiometabolic biomarkers as well as the microbiome and urine bacterial metabolites. The project will be led by the PI and conducted by a team of PhD students and postdoc in close collaboration with relevant experts. It will be initiated early on and continued throughout a 4-year study period.

With this research, the investigators attempt to provide the strongest scientific evidence with etiologically more relevant exposure-disease associations and to shape future health risk assessments.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • SMC and COSM
  • Born between 1914 and 1948 (SMC) or through 1952 (COSM)
  • Residing in Västmanland and Uppsala counties (SMC)
  • Residing in Västmanland and Örebro counties (COSM)
  • BAMSE cohort
  • All children born in certain areas of northern and central Stockholm between Feb 1994 and Nov 1996.

排除标准

  • SMC and COSM
  • Incorrect or missing national registration number
  • Prevalent disease at baseline (depending on research question)
  • Implausible energy intake
  • BAMSE cohort
  • The family planned to move within 1 year of the study start;
  • Insufficient knowledge of the Swedish language;
  • The family had a seriously ill child or
  • an older sister or brother was already included in the study.

研究组 & 干预措施

Swedish Mammography Cohort (SMC)

Cohort of Swedish Men (COSM)

Barn, Allergi, Miljö, Stockholm, Epidemiologi (BAMSE)

结局指标

主要结局

Gastrointestinal cancers incidence

时间窗: Through study completion, an average of 25 years

In SIMPLER cohorts

Cardiovascular diseases incidence

时间窗: Through study completion, an average of 25 years

In SIMPLER cohorts

Chronic obstructive pulmonary disease incidence

时间窗: Through study completion, an average of 25 years

In SIMPLER cohorts

Differential abundance of gut microbiota sequenced using DNBseq

时间窗: At baseline (time of sample collection)

In SIMPLER cohorts and sequenced using DNBseq technology (BGI) and computationally analysed using both MetaPhlAn4 and CHAMP (CM HumAn Microbiome Profiler 2.0, Clinical Microbiomics)

Asthma incidence

时间窗: From birth through young adulthood (up to 24 years of age)

In BAMSE cohort

Lung function (FEV1 and FVC)

时间窗: Assessed every 8 years

In BAMSE cohort and measured using spirometry according to the ATS/ERS spirometry criteria (at age 8 years using a 2200 Pulmonary Function Laboratory (SensorMedics), at 16 years of age using a Jaeger MasterScreen-IOS system (CareFusion Technologies), and at 24 years using a Vyaire Vyntus system (Vyaire Medical))

Concentrations of inflammatory biomarkers assessed by Olink Inflammation panel

时间窗: At 24 years of age

In BAMSE cohort, using the Olink Target 96 Inflammation panel, which measures relative protein levels reported as Normalized Protein eXpression (NPX) values on a log2 scale. All proteins included in the panel (approximately 92) will be analyzed individually in an exploratory manner.

次要结局

  • Urinary bacterial metabolite profiles assessed by non-targeted LC-HRMS(At 24 years of age)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Agneta Åkesson

Professor

Karolinska Institutet

研究点 (1)

Loading locations...

相似试验